Precigen Reported Q2 Revenue for Papzimeos
The Germantown-based biopharmaceutical firm generated $53.1 million from its immunotherapy drug in the second quarter of 2026.
Live Poll
Should local governments prioritize investments to attract and expand the biotech industry in your area?